Medifast, Inc. MED

Set alert

Price alert · MED

All alert types
12.53 USD +0.38 +3.13%

At close · Nov 2

12.53 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
12.54 × 300
Ask
12.65 × 300
12.25 Day range 12.58
9.22 52-week range 13.45
YTD
+17.32%
1 year
+4.24%
Open
12.36
Prev close
12.15
Mkt cap
140.12M
Vol
93.65K
Avg vol
143.63K
EPS
-3.70
P/E
0.00
Div yield
34.41%
More statistics
Low
12.25
High
12.58
Forward P/E
56.17
Beta
1.16
Short ratio
7.68
Inst. own
86.16%
Dividend
6.60
Ex-div date
Sep 17, 2023
50-d avg
18.72
200-d avg
22.71
1y target
16.50

5Y chart

Chart tools
Interval

Events in this range
  • Dec 20, 2021Dividend: 1.42
  • Mar 28, 2022Dividend: 1.64
  • Jun 27, 2022Dividend: 1.64
  • Sep 19, 2022Dividend: 1.64
  • Dec 19, 2022Dividend: 1.64
  • Feb 7, 2023Dividend: 1.64
  • Mar 27, 2023Dividend: 1.65
  • Jun 26, 2023Dividend: 1.65
  • Aug 7, 2023Earnings: 2.77; estimate 1.44; surprise 92.36%
  • Sep 18, 2023Dividend: 1.65
  • Oct 13, 2023Rating: Stephens & Co. · — → Equal-Weight
  • Nov 6, 2023Earnings: 2.12; estimate 1.02; surprise 107.84%
  • Feb 20, 2024Earnings: 1.09; estimate 0.99; surprise 10.1%
  • Feb 21, 2024Rating: DA Davidson · Neutral → Neutral
  • Apr 29, 2024Earnings: 0.66; estimate 0.78; surprise -15.38%
  • Apr 30, 2024Rating: DA Davidson · Neutral → Neutral
  • Jun 5, 2024Downgrade: DA Davidson · Neutral → Underperform
  • Jul 22, 2024Rating: DA Davidson · Underperform → Underperform
  • Aug 5, 2024Earnings: 0.92; estimate 0.36; surprise 155.56%
  • Nov 4, 2024Earnings: 0.35; estimate -0.15; surprise 333.33%
  • Nov 5, 2024Rating: DA Davidson · Underperform → Neutral
Signals (91)
NameDateAgo
SMA: BullishOct 26, 20261 week ago
SMA: BearishSep 28, 20261 month ago
SMA: BullishAug 3, 20263 months ago
SMA: BullishAug 3, 20263 months ago
MACD: Buy SignalAug 3, 20263 months ago
MACD: Sell SignalJul 6, 20263 months ago
SMA: BearishJun 15, 20264 months ago
SMA: BearishJun 15, 20264 months ago
SMA: BullishMay 4, 20266 months ago
SMA: BullishApr 13, 20266 months ago
MACD: Buy SignalApr 13, 20266 months ago
MACD: Sell SignalMar 9, 20267 months ago
SMA: BearishFeb 2, 20269 months ago
MACD: Buy SignalJan 12, 20269 months ago
SMA: BullishJan 5, 202610 months ago
SMA: BearishDec 22, 202510 months ago
SMA: BullishDec 8, 202510 months ago
MACD: Sell SignalOct 27, 20251 year ago
SMA: BearishOct 6, 20251 year ago
SMA: BearishOct 6, 20251 year ago
SMA: BullishSep 29, 20251 year ago
SMA: BearishSep 22, 20251 year ago
SMA: BullishSep 8, 20251 year ago
SMA: BullishSep 8, 20251 year ago
SMA: BearishSep 1, 20251 year ago
SMA: BearishSep 1, 20251 year ago
SMA: BullishAug 18, 20251 year ago
SMA: BullishAug 18, 20251 year ago
SMA: BearishJul 28, 20251 year ago
SMA: BearishJul 28, 20251 year ago
SMA: BullishJul 21, 20251 year ago
SMA: BullishJul 21, 20251 year ago
SMA: BearishJul 14, 20251 year ago
SMA: BearishJul 14, 20251 year ago
SMA: BullishJun 30, 20251 year ago
SMA: BullishJun 16, 20251 year ago
SMA: BearishJun 2, 20251 year ago
SMA: BullishMay 12, 20251 year ago
RSI: OversoldApr 7, 20251 year ago
SMA: BearishDec 16, 20241 year ago
SMA: BearishDec 9, 20241 year ago
SMA: BullishDec 2, 20241 year ago
SMA: BullishNov 25, 20241 year ago
SMA: BearishNov 11, 20241 year ago
SMA: BullishOct 28, 20242 years ago
SMA: BearishAug 26, 20242 years ago
SMA: BullishAug 19, 20242 years ago
SMA: BearishAug 5, 20242 years ago
RSI: OversoldAug 5, 20242 years ago
SMA: BullishJul 29, 20242 years ago
MACD: Buy SignalJun 3, 20242 years ago
MACD: Sell SignalJan 15, 20242 years ago
RSI: OversoldJan 15, 20242 years ago
SMA: BearishDec 11, 20232 years ago
SMA: BullishDec 4, 20232 years ago
MACD: Buy SignalDec 4, 20232 years ago
RSI: OversoldNov 6, 20232 years ago
MACD: Sell SignalSep 18, 20233 years ago
SMA: BearishAug 14, 20233 years ago
SMA: BearishJul 31, 20233 years ago
SMA: BullishJul 24, 20233 years ago
SMA: BullishJun 19, 20233 years ago
MACD: Buy SignalJun 19, 20233 years ago
RSI: OversoldJun 5, 20233 years ago
RSI: OversoldMay 22, 20233 years ago
MACD: Sell SignalApr 3, 20233 years ago
MACD: Buy SignalMar 27, 20233 years ago
MACD: Sell SignalMar 20, 20233 years ago
SMA: BearishJan 16, 20233 years ago
SMA: BullishJan 2, 20233 years ago
SMA: BearishDec 12, 20223 years ago
SMA: BullishNov 14, 20223 years ago
MACD: Buy SignalNov 7, 20223 years ago
RSI: OversoldOct 31, 20224 years ago
RSI: OversoldSep 12, 20224 years ago
RSI: OversoldAug 15, 20224 years ago
MACD: Sell SignalAug 1, 20224 years ago
SMA: BearishJul 4, 20224 years ago
SMA: BearishJun 27, 20224 years ago
SMA: BullishJun 20, 20224 years ago
SMA: BullishJun 20, 20224 years ago
SMA: BearishJun 13, 20224 years ago
SMA: BearishJun 13, 20224 years ago
SMA: BullishJun 6, 20224 years ago
SMA: BullishMay 30, 20224 years ago
SMA: BearishMay 16, 20224 years ago
SMA: BullishMay 2, 20224 years ago
SMA: BearishApr 18, 20224 years ago
SMA: BullishApr 11, 20224 years ago
RSI: OversoldFeb 14, 20224 years ago
SMA: BearishJan 10, 20224 years ago

Key statistics

Market cap
184.30M
Enterprise value
27.90M
Trailing P/E
25.15
Forward P/E
56.17
PEG ratio
0.00
Price / sales
0.27
Price / book
0.87
EPS (TTM)
0.67
Beta
1.16
Dividend yield
34.41%
Payout ratio
0.00%
Profit margin
1.09%
Revenue (TTM)
674.48M
Revenue growth
-40.60%
Free cash flow
-7.09M
Total cash
169.96M
Total debt
17.63M
Return on equity
3.66%
Shares outstanding
10.94M
Short % of float
22.52%
50-day average
18.72
200-day average
22.71

Analyst view

Consensus: none

Price target (mean) 16.50 +31.7% upside
Target (low)
16.00
Target (mean)
16.50
Target (high)
17.00
Ratings (0m) 2 0 buy · 2 hold · 0 sell
  • Strong buy0
  • Buy0
  • Hold2
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate -0.16.

Earnings history

Financials — quick view

All financials
MED Revenue — quarterly 72.05M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
MED Net income — quarterly -17.51M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
MED EPS — quarterly -1.57
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

MED recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 4, 2024Sep 1, 2024-0.150.35+0.50+333.33%
Aug 5, 2024Jun 1, 20240.360.92+0.56+155.56%
Apr 29, 2024Mar 1, 20240.780.66-0.12-15.38%
Feb 20, 2024Dec 1, 20230.991.09+0.10+10.10%
Nov 6, 2023Sep 1, 20231.022.12+1.10+107.84%
Aug 7, 2023Jun 1, 20231.442.77+1.33+92.36%

Upgrades / downgrades

MED analyst upgrades and downgrades
DateFirmActionFromTo
Nov 5, 2024DA DavidsonupUnderperformNeutral
Jul 22, 2024DA DavidsonmainUnderperformUnderperform
Jun 5, 2024DA DavidsondownNeutralUnderperform
Apr 30, 2024DA DavidsonmainNeutralNeutral
Feb 21, 2024DA DavidsonmainNeutralNeutral
Oct 13, 2023Stephens & Co.init—Equal-Weight

About Medifast, Inc.

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Sector
Consumer Cyclical
Industry
Personal Services
Country
United States

News

Your note

Sign in to keep a note on MED — it syncs with the Stock Master app.

Insider holders

MED insider holders
InsiderRelationLatest transactionDateShares held
BROWN JEFFREY J.DirectorStock Award(Grant)Jun 19, 202422,193
CHARD DANIEL RChief Executive OfficerStock Award(Grant)Mar 12, 2024211,828
GEARY ELIZABETH A.DirectorStock Award(Grant)Jun 19, 20248,377
HALLQUIST CONSTANCE JFormerSaleOct 5, 20230
HOER MICHAEL A.DirectorStock Award(Grant)Jun 19, 202414,971
MACKENZIE JONATHAN BARRETTOfficerStock Award(Grant)Mar 12, 20244,051

Institution ownership

MED institution ownership
Holder% heldSharesValueReported
Renaissance Technologies, LLC9.20%1,006,21016.95MSep 29, 2024
Blackrock Inc.8.01%876,11414.76MSep 29, 2024
Vanguard Group Inc6.64%726,16712.24MSep 29, 2024
AQR Capital Management, LLC3.52%384,5986.48MSep 29, 2024
Morgan Stanley2.93%321,0075.41MSep 29, 2024
Bank of America Corporation2.88%314,7285.30MSep 29, 2024

Fund ownership

MED fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund3.26%356,8666.01MSep 29, 2024
iShares Russell 2000 ETF2.68%292,7684.93MOct 30, 2024
Avantis U.S. Small Cap Value ETF1.84%201,5863.40MSep 29, 2024
Vanguard Extended Market Index Fund1.48%162,0052.73MSep 29, 2024
Vanguard Consumer Staples Index Fund1.17%127,5452.15MAug 30, 2024
Federated Hermes MDT Small Cap Core Fund1.15%125,5632.12MJul 30, 2024